In a very recent study, Wirakiat and co-workers analyzed the relationship between PRDX1 and a transcription factor eEF1A2 during neuronal differentiation and in SH-SY5Y cells treated with a neurotoxin 1-methyl-4-phenylpyridinium (MPP+), a model of PD. This evidence concerns the gene PRDX1 and Parkinson disease.